Clene Inc. CLNN
3.92 USD -0.08 (-2.00%)
Regular-session close
3.72 -0.20 -5.10%
Pre-market · Nov 16, 8:35 AM ET
3.86 Day range 4.43
3.02 52-week range 10.84
- YTD
- -33.22%
- 1 year
- -46.30%
News
businesswire.com Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene…benzinga.com Clene Q3 EPS $0.05 Beats $(0.45) Estimate, Sales $56.000K Miss $74.000K Estimate Clene (NASDAQ:CLNN) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.45) by 111.11 percent. This is a 105.88 percent increase over losses of $(0.85) per…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers SCWorx (NASDAQ:WORX) stock moved upwards by 42.9% to $3.83 during Tuesday's regular session. Myriad Genetics (NASDAQ:MYGN) shares moved upwards by 36.85% to $5.76. The company's market cap…
benzinga.com Why 3M Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket 3M shares rose 4.4% premarket after expanding its Amazon data-center deal, including a $521.4M stock warrant; other stocks saw sharp moves.benzinga.com HC Wainwright & Co. Reiterates Buy on Clene, Maintains $31 Price Target HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $31 price target.
